Using INOpulse Nitric Oxide Device Improves Blood Flow in Lungs in PH-PF, New Trial Data Suggest

Use of Bellerophon Therapeutics’ INOpulse device — which provides nitric oxide to the lungs — significantly improved parameters related to blood flow in the lungs in people with pulmonary hypertension associated with pulmonary fibrosis (PH-PF), top-line data from…

Bellerophon’s INOPulse Device Leads to Clinically Meaningful Improvements in PH-ILD, Early Data Shows

Use of Bellerophon Therapeutics’s INOpulse device led to clinically meaningful improvements in people with pulmonary hypertension associated with interstitial lung disease (PH-ILD), according to initial data from an ongoing clinical study. PH-ILD is associated with constriction or narrowing of pulmonary arteries, which supply the lungs with…